
The study aimed to compare the efficacy of surfactant alone versus a combination of surfactant and budesonide in managing bronchopulmonary dysplasia (BPD) and mortality rates among premature infants with RDS. The study involved 134 premature infants with respiratory distress syndrome (RDS) who were enrolled Utilizing covariate adaptive randomization, participants were allocated into two groups. Subgroup analysis revealed that administering surfactant with budesonide notably reduced mortality rates in infants under 30 weeks of age. Additionally, positive effects were observed in various clinical parameters in infants under 34 weeks compared to older infants. The study suggests potential benefits of combination therapy, particularly in preterm infants under 34 weeks gestational age and 1500 grams birth weight.
Like
Save
Share